Xarelto for Thromboprophylaxis After Total Hip and Total Knee Arthroplasty

NARecruitingINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

February 1, 2023

Primary Completion Date

December 21, 2025

Study Completion Date

December 21, 2025

Conditions
Venous ThromboembolismArthroplasty
Interventions
DRUG

Rivaroxaban 10 MG

Patients are randomly divided into two groups. One group receives no prophylaxis with an anticoagulant, the other one receives Rivaroxaban. The dosage of Rivaroxaban is 10 mg given orally once daily starting on the day of the surgery and continuing the following 13 days.

Trial Locations (1)

60002

RECRUITING

Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi City

All Listed Sponsors
lead

Chiayi Christian Hospital

OTHER